No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer...
No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer： a 5-year follow-up study
About this item
Full title
Author / Creator
Publisher
China: Medknow Publications and Media Pvt. Ltd
Journal title
Language
English
Formats
Publication information
Publisher
China: Medknow Publications and Media Pvt. Ltd
Subjects
More information
Scope and Contents
Contents
Prior studies suggested that the use of androgen deprivation therapy （ADT） in patients with prostate cancer （PC） might cause the impairment of cognitive function which is one of the common symptoms of dementia; however, the association between ADT and cognitive impairment still remains controversial. This retrospective cohort study aimed to investi...
Alternative Titles
Full title
No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer： a 5-year follow-up study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5507085
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5507085
Other Identifiers
ISSN
1008-682X
E-ISSN
1745-7262
DOI
10.4103/1008-682X.179528
